D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 23,177 464 World Ranking 9306 National Ranking 4942
Biology and Biochemistry D-index 86 Citations 23,208 427 World Ranking 1938 National Ranking 1087

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

Michael R. Freeman spends much of his time researching Internal medicine, Cell biology, Cancer research, Prostate cancer and Cancer. Michael R. Freeman has included themes like Endocrinology and Cardiology in his Internal medicine study. His work investigates the relationship between Cell biology and topics such as Cancer cell that intersect with problems in Microvesicles.

His research integrates issues of Cell culture, Epidermal growth factor, Cell growth, Immunology and LNCaP in his study of Cancer research. His study in Prostate cancer is interdisciplinary in nature, drawing from both Prostate, Oncology, Cholesterol, Tumor progression and Advanced disease. His Cancer research integrates issues from Extracellular vesicles and Pathology.

His most cited work include:

  • Single photon-emission computed tomography (488 citations)
  • Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts (404 citations)
  • Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. (377 citations)

What are the main themes of his work throughout his whole career to date?

Michael R. Freeman mainly focuses on Internal medicine, Cancer research, Prostate cancer, Cardiology and Cell biology. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Oncology. His Endocrinology research focuses on Growth factor and how it connects with Epidermal growth factor.

His research on Cancer research also deals with topics like

  • Cancer cell and related Microvesicles,
  • Cell culture most often made with reference to Cell growth. His Prostate cancer research entails a greater understanding of Cancer. His research investigates the connection between Cardiology and topics such as Asymptomatic that intersect with problems in Ischemia.

He most often published in these fields:

  • Internal medicine (52.09%)
  • Cancer research (34.79%)
  • Prostate cancer (29.69%)

What were the highlights of his more recent work (between 2015-2021)?

  • Prostate cancer (29.69%)
  • Cancer research (34.79%)
  • Internal medicine (52.09%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Prostate cancer, Cancer research, Internal medicine, Cancer and Oncology. Michael R. Freeman combines subjects such as Transcriptome, Prostate and Metastasis, Circulating tumor cell with his study of Prostate cancer. In his study, Molecular biology is strongly linked to Cancer cell, which falls under the umbrella field of Prostate.

His Cancer research study also includes fields such as

  • RNA, which have a strong connection to Microvesicles,
  • Tumor progression together with Tube formation. His Internal medicine study incorporates themes from Endocrinology, Radiology, Pharmacology and Cardiology. His Cancer research is multidisciplinary, relying on both Cell signaling, Downregulation and upregulation, Quantitative proteomics and Pathology.

Between 2015 and 2021, his most popular works were:

  • Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma. (122 citations)
  • Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome (90 citations)
  • MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer. (70 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Cancer

His primary areas of study are Prostate cancer, Cancer, Internal medicine, Cancer research and Prostate. His Prostate cancer study combines topics in areas such as Therapeutic resistance, Metastasis, Signalling pathways and Adenocarcinoma. His Cancer research incorporates themes from Cell, Cell type, Cell culture, Bioinformatics and Receptor.

His work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology. The various areas that Michael R. Freeman examines in his Cancer research study include Cell signaling, Circulating tumor cell, DU145, Kinase activity and Androgen receptor. His Prostate research is multidisciplinary, incorporating perspectives in Clinical trial, Preventive healthcare, Statin, Tertiary Prevention and Cholesterol.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes.

Valentina R. Minciacchi;Michael R. Freeman;Dolores Di Vizio;Dolores Di Vizio;Dolores Di Vizio.
Seminars in Cell & Developmental Biology (2015)

674 Citations

Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts

Liyan Zhuang;Jayoung Kim;Rosalyn M. Adam;Keith R. Solomon.
Journal of Clinical Investigation (2005)

603 Citations

F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Rob S.B. Beanlands;Graham Nichol;Ella Huszti;Dennis Humen.
Journal of the American College of Cardiology (2007)

522 Citations

Single photon-emission computed tomography

Thomas A. Holly;Brian G. Abbott;Mouaz Al-Mallah;Dennis A. Calnon.
Journal of Nuclear Cardiology (2010)

519 Citations

Peripheral Blood T Lymphocytes and Lymphocytes Infiltrating Human Cancers Express Vascular Endothelial Growth Factor: A Potential Role for T Cells in Angiogenesis

Michael R. Freeman;Francis X. Schneck;Michael L. Gagnon;Christopher Corless.
Cancer Research (1995)

506 Citations

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo

J. L. Camps;Shi-Ming Chang;T. C. Hsu;M. R. Freeman.
Proceedings of the National Academy of Sciences of the United States of America (1990)

479 Citations

T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells.

Srully Blotnick;George E. Peoples;Michael R. Freeman;Timothy J. Eberlein.
Proceedings of the National Academy of Sciences of the United States of America (1994)

423 Citations

Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease.

Dolores Di Vizio;Jayoung Kim;Martin H. Hager;Matteo Morello.
Cancer Research (2009)

392 Citations

Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro.

Anthony Atala;Joseph P. Vacanti;Craig A. Peters;James Mandell.
The Journal of Urology (1992)

387 Citations

Cholesterol-rich Lipid Rafts Mediate Akt-regulated Survival in Prostate Cancer Cells

Liyan Zhuang;Jianqing Lin;Michael L Lu;Keith R Solomon.
Cancer Research (2002)

355 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael R. Freeman

Anthony Atala

Anthony Atala

Wake Forest University

Publications: 133

Daniel S. Berman

Daniel S. Berman

Cedars-Sinai Medical Center

Publications: 101

Rob S. Beanlands

Rob S. Beanlands

University of Ottawa

Publications: 64

Michael P. Lisanti

Michael P. Lisanti

University of Salford

Publications: 60

Leland W.K. Chung

Leland W.K. Chung

Cedars-Sinai Medical Center

Publications: 55

Federica Sotgia

Federica Sotgia

University of Salford

Publications: 55

Guido Germano

Guido Germano

Cedars-Sinai Medical Center

Publications: 53

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 43

Piotr J. Slomka

Piotr J. Slomka

Cedars-Sinai Medical Center

Publications: 42

Natalia Prevarskaya

Natalia Prevarskaya

University of Lille

Publications: 40

Dan H. Barouch

Dan H. Barouch

Harvard Medical School

Publications: 38

René J. M. Bindels

René J. M. Bindels

Radboud University Nijmegen

Publications: 33

James J. Yoo

James J. Yoo

Wake Forest University

Publications: 32

John D. Friedman

John D. Friedman

Cedars-Sinai Medical Center

Publications: 30

Robert M. Califf

Robert M. Califf

Duke University

Publications: 30

Richard G. Pestell

Richard G. Pestell

The Wistar Institute

Publications: 29

Trending Scientists

Guy Laroque

Guy Laroque

University College London

Luis M. Bergasa

Luis M. Bergasa

University of Alcalá

Giancarlo Aldini

Giancarlo Aldini

University of Milan

Bingfu Lei

Bingfu Lei

South China Agricultural University

David Evans Walter

David Evans Walter

University of the Sunshine Coast

Keld Danø

Keld Danø

Copenhagen University Hospital

Dimitrios Rizos

Dimitrios Rizos

Asociación de Investigación de la Industria Agroalimentaria

Richard L. Ward

Richard L. Ward

Cincinnati Children's Hospital Medical Center

Marcus Christl

Marcus Christl

ETH Zurich

Francesco Pallone

Francesco Pallone

University of Rome Tor Vergata

Gerald J. Gorn

Gerald J. Gorn

Hong Kong Polytechnic University

J. Richard Jennings

J. Richard Jennings

University of Pittsburgh

Jonathon Leipsic

Jonathon Leipsic

University of British Columbia

Pierre Lasjaunias

Pierre Lasjaunias

University of Paris-Sud

Giovanni Sartor

Giovanni Sartor

University of Bologna

Something went wrong. Please try again later.